There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Neuronetics (STIM
In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on Sientra (SIEN), with a price target of $9.00. The company's
In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on Sientra (SIEN – Research Report),
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 6.) * Forty Seven Inc (NASDAQ: FTSV) * Masimo Corporat
After Stifel Nicolaus and Leerink Partners gave Zimmer Biomet Holdings (NYSE: ZBH) a Buy rating last month, the company received another Buy, this time
After Stifel Nicolaus and Leerink Partners gave Zimmer Biomet Holdings (NYSE: ZBH) a Buy rating last month, the company received
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Penumbra (PEN) and SeaSpine Holdings (SPNE) with bullish
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Penumbra ( PEN – Research Report ) and SeaSpine Holdings ( SPNE – Research Report ) with bullish se
In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on SI-Bone (SIBN), with a price target of $27.00. The company's
In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on SI-Bone (SIBN – Research Report),
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Atara Biotherapeutics (ATRA), Misonix (MSON) and BioNTech
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Atara Biotherapeutics
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nevro Crop (NVRO), Inspire Medical Systems (INSP) and AxoGen (AXGN).
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Nevro Crop (NVRO – Research
In a report released yesterday, Kyle Rose from Canaccord Genuity maintained a Buy rating on Stryker (SYK), with a price target of $240.00. The company's
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE